Morphological and behavioral changes induced by transgenic overexpression of interleukin-1ra in the brain

Journal of Neuroscience Research

Volumn 89, Issue 2, 2011, Pages 142-152

  Spulber, Stefan ^a   Bartfai, Tamas ^b   Winblad, Bengt ^a   Schultzberg, Marianne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Brain morphology; Interleukin 1 receptor antagonist; Magnetic resonance imaging; Multivariate analysis

Indexed keywords

FORMALDEHYDE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BRAIN; BRAIN DEVELOPMENT; CONTROLLED STUDY; GAIT; GENE OVEREXPRESSION; GENOTYPE; HETEROZYGOTE; MALE; MATING; MORPHOLOGY; MOTOR PERFORMANCE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL LEAST SQUARES REGRESSION; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FOOTPRINTING; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL; STEREOMETRY; SWIMMING; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NEUROGENESIS; SIGNAL TRANSDUCTION;

EID: 78650225186     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22534     Document Type: Article

References (35)

1. Allan SM. 2000. The role of pro- and antiinflammatory cytokines in neurodegeneration. Ann N Y Acad Sci 917: 84-93.
2. Augustsson H, Meyerson BJ. 2004. Exploration and risk assessment: a comparative study of male house mice (Mus musculus musculus) and two laboratory strains. Physiol Behav 81: 685-698.
3. Augustsson H, Dahlborn K, Meyerson BJ. 2005. Exploration and risk assessment in female wild house mice (Mus musculus musculus) and two laboratory strains. Physiol Behav 84: 265-277.
4. Ban E, Milon G, Prudhomme N, Fillion G, Haour F. 1991. Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43: 21-30.
5. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. 1999. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19: 3248-3257.
6. Caviness VS, Bhide PG, Nowakowski RS. 2008. Histogenetic processes leading to the laminated neocortex: migration is only a part of the story. Dev Neurosci 30: 82-95.
7. Choi BH. 1988. Prenatal gliogenesis in the developing cerebrum of the mouse. Glia 1: 308-316.
8. Dantzer R, Kelley KW. 2007. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21: 153-160.
9. Dziegielewska KM, Moller JE, Potter AM, Ek J, Lane MA, Saunders NR. 2000. Acute-phase cytokines IL-1β and TNF-α in brain development. Cell Tissue Res 299: 335-345.
10. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB. 1988. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 8: 709-714.
11. Golan H, Stilman M, Lev V, Huleihel M. 2006. Normal aging of offspring mice of mothers with induced inflammation during pregnancy. Neuroscience 141: 1909-1918.
12. Goshen I, Kreisel T, Ounallah-Saad H, Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E, Yirmiya R. 2007. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 32: 1106-1115.
13. Goss JR, Finch CE, Morgan DG. 1991. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging 12: 165-170.
14. Kaffman A, Meaney MJ. 2007. Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. J Child Psychol Psychiatry 48: 224-244.
15. Koo JW, Duman RS. 2008. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 105: 751-756.
16. Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Östlund P, Engfors C, Alheim K, Bartfai T, Iverfeldt K, Schultzberg M. 1999. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol 276: R644-R651.
17. Meyer U, Feldon J, Fatemi SH. 2009. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 33: 1061-1079.
18. Meyerson BJ, Augustsson H, Berg M, Roman E. 2006. The concentric square field: a multivariate test arena for analysis of explorative strategies. Behav Brain Res 168: 100-113.
19. Mouton PR, Long JM, Lei DL, Howard V, Jucker M, Calhoun ME, Ingram DK. 2002. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res 956: 30-35.
20. 1H MRS in APP/PS1 mice. Neurobiol Aging 29: 1423-1433.
21. Opricǎ M, Zhu S, Goiny M, Pham TM, Mohammed AH, Winblad B, Bartfai T, Schultzberg M. 2005. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behavior, serum corticosterone and brain monoamines. Brain Behav Immun 19: 223-234.
22. Opricǎ M, Hjorth E, Spulber S, Popescu BO, Ankarcrona M, Winblad B, Schultzberg M. 2007. Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist. J Cell Mol Med 11: 810-825.
23. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. 2006. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59: 546-554.
24. Parish CL, Finkelstein DI, Tripanichkul W, Satoskar AR, Drago J, Horne MK. 2002. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J Neurosci 22: 8034-8041.
25. Priebe K, Romeo RD, Francis DD, Sisti HM, Mueller A, McEwen BS, Brake WG. 2005. Maternal influences on adult stress and anxiety-like behavior in C57BL/6J and BALB/cJ mice: a cross-fostering study. Dev Psychobiol 47: 398-407.
26. Ruetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K. 2005. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol 196: 273-281.
27. Sandhir R, Puri V, Klein RM, Berman NE. 2004. Differential expression of cytokines and chemokines during secondary neuron death following brain injury in old and young mice. Neurosci Lett 369: 28-32.
28. Spulber S, Oprica M, Bartfai T, Winblad B, Schultzberg M. 2008. Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci 27: 549-558.
29. Spulber S, Bartfai T, Schultzberg M. 2009. IL-1/IL-1ra balance in the brain revisited-evidence from transgenic mouse models. Brain Behav Immun 90: 256-262.
30. Takao T, Tracey DE, Mitchell WM, De Souza EB. 1990. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127: 3070-3078.
31. Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF. 1999. Dynamic regulation of the proinflammatory cytokine, interleukin-1β: molecular biology for nonmolecular biologists. Life Sci 65: 449-481.
32. Westman E, Spenger C, Wahlund LO, Lavebratt C. 2007. Carbamazepine treatment recovered low N-acetylaspartate + N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph). Neurobiol Dis 26: 221-228.
33. Xie Z, Morgan TE, Rozovsky I, Finch CE. 2003. Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Exp Neurol 182: 135-141.
34. Zaharia MD, Kulczycki J, Shanks N, Meaney MJ, Anisman H. 1996. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors. Psychopharmacology 128: 227-239.
35. Zuckerman L, Weiner I. 2005. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39: 311-323.